BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang WT, Zhao XQ, Li GP, Chen YZ, Wang L, Han MF, Li WN, Chen T, Chen G, Xu D, Ning Q, Zhao XP. Immune response pattern varies with the natural history of chronic hepatitis B. World J Gastroenterol 2019; 25(16): 1950-1963 [PMID: 31086463 DOI: 10.3748/wjg.v25.i16.1950]
URL: https://www.wjgnet.com/1007-9327/full/v25/i16/1950.htm
Number Citing Articles
Hye Won Lee, Henry Lik-Yuen Chan. Unresolved issues of immune tolerance in chronic hepatitis BJournal of Gastroenterology 2020; 55(4): 383 doi: 10.1007/s00535-020-01665-z
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Md. Helal Uddin, Md. Sakirul Islam Khan, Osamu Yoshida, Eduardo Penton, Guillen Nieto Gerardo, Yoichi Hiasa. Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinicalExploration of Medicine 2021;  doi: 10.37349/emed.2021.00058
Ailyn Fadriquela, Cheol-Su Kim, Kyu-Jae Lee, Seong Hee Kang, Moon Young Kim, Jong-Han Lee. Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patientsJournal of Clinical Pathology 2021; : jclinpath-2020-207125 doi: 10.1136/jclinpath-2020-207125
Dafeng Liu, Lingyun Zhou, Xinyi Zhang, Yilan Zeng, Lang Bai, Dongbo Wu, Hong Tang, Arturo Bevilacqua. Significantly Decreased Islet β Cell Function is Closely Associated with Hyperglycemia in Chronic Hepatitis B PatientsInternational Journal of Endocrinology 2021; 2021: 1 doi: 10.1155/2021/1264707
Marina Campos-Valdez, Hugo C. Monroy-Ramírez, Juan Armendáriz-Borunda, Laura V. Sánchez-Orozco. Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus VariabilityViruses 2021; 13(6): 1167 doi: 10.3390/v13061167
María B Pisano, Cecilia G Giadans, Diego M Flichman, Viviana E Ré, María V Preciado, Pamela Valva. Viral hepatitis update: Progress and perspectives World Journal of Gastroenterology 2021; 27(26): 4018-4044 doi: 10.3748/wjg.v27.i26.4018
Florian Bömmel, Thomas Berg. Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis BHepatology Communications 2021; 5(10): 1632 doi: 10.1002/hep4.1708
Paola Fisicaro, Marzia Rossi, Andrea Vecchi, Greta Acerbi, Valeria Barili, Diletta Laccabue, Ilaria Montali, Alessandra Zecca, Amalia Penna, Gabriele Missale, Carlo Ferrari, Carolina Boni. The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV TherapyInternational Journal of Molecular Sciences 2019; 20(20): 5080 doi: 10.3390/ijms20205080
Hui Li, Yan Wang, Shizhao Ma, Chaoqun Zhang, Hua Liu, Dianxing Sun. Clinical significance of small molecule metabolites in the blood of patients with different types of liver injuryScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91164-9